Dermatology

Filter

Enfortumab Vedotin-Induced Skin Reactions Linked to Better Survival

August 2026

Patients who developed enfortumab vedotin-induced cutaneous adverse events experienced significantly longer progression free and overall survival, suggesting these skin reactions may have prognostic value during treatment.

Enfortumab Vedotin-Induced Skin Reactions Linked to Better Survival

Patients who developed enfortumab vedotin-induced cutaneous adverse events experienced significantly longer progression free and overall survival, suggesting these skin reactions may have prognostic value during treatment.

Virtual Support Improved Quality of Life in Vulvar Lichen Sclerosus

Expert-led virtual support significantly improved quality of life in women with vulvar lichen sclerosus, supporting its role alongside medical therapy.

Rare Ichthyosis Burden and Comorbidities in England - EMJ

Rare Ichthyosis Linked to Higher Comorbidity Burden

A national study found that rare ichthyosis was associated with increased systemic comorbidities, earlier mortality, and limited genetic testing, providing important evidence to guide future healthcare planning.

Delgocitinib Cream Showed Dose Dependent Benefits in Atopic Dermatitis

An 8 week Phase IIb trial found that delgocitinib cream produced dose dependent improvements in adults with mild to severe atopic dermatitis while maintaining a favourable safety profile compared with cream vehicle.

Stevens Johnson Syndrome Risk Highest with Lamotrigine

A nationwide cohort quantified Stevens Johnson syndrome and toxic epidermal necrolysis risk after antiseizure medication initiation.

Photosensitive Disease Scoring Improved with UV Weighting - EMJ

UV-Weighted Scoring Improves Photosensitive Disease Assessment

Researchers have developed a UV-weighted scoring system that could improve the assessment of photosensitive skin diseases by reducing body surface area-related bias.

High-Dose Vitamin D Eases Cancer Therapy Skin Toxicity

High-dose oral vitamin D was associated with rapid improvement in chemotherapy- and radiation-induced skin toxicity in a multicentre case series of 33 patients.

Rituximab Supports First-Line Treatment in Pemphigus Foliaceus

A meta-analysis found rituximab achieved complete remission in 75% of patients with pemphigus foliaceus, supporting its use as first-line treatment.

Loading posts...

1 2 3 … 53 Next »